Bristol-Myers Squibb makes internal promotion for new EVP and CCO

Christopher Boerner joined BMS in 2015 from Seattle Genetics where he was executive vice president of commercial. He has now been promoted from head of international markets at BMS to executive vice president and chief commercial officer.

BMS chairman and CEO, Giovanni Caforio, said: “Chris brings a deep knowledge of specialty care markets, a clear focus on innovation, and a proven track record of successful execution. Since joining BMS, he has successfully led our commercial organization across the U.S. and international markets. I am confident he will build upon the company’s solid foundation and continue to strengthen our ability to bring medicines to patients faster.”

Mr Boerner said: “I’m very excited to lead such a talented and diverse commercial team globally,” Boerner said in a statement. “Along with my commercial colleagues, I look forward to continuing to help BMS deliver on our mission of bringing transformational medicines to patients.”